Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

Value in Health - Tập 15 Số 6 - Trang 835-842 - 2012
Andrew Briggs1, Milton C. Weinstein2, Elisabeth Fenwick1, Jonathan Karnon3, Mark Sculpher4, A. David Paltiel5
1Health Economics and Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK
2Harvard School of Public Health, Boston, MA, USA
3School of Population Health and Clinical Practice, University of Adelaide, SA, Australia
4Centre for Health Economics, University of York, York, UK
5Yale School of Medicine & Yale School of Management, New Haven, CT, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Caro, 2012, Modeling good research practices—overview: a report of the ISPOR-SMDM modeling good research practices task force-1, Value Health, 15, 796, 10.1016/j.jval.2012.06.012

Roberts, 2012, Conceptualizing a model: A report of the ISPOR-SMDM modeling good research practices task force-2, Value Health, 15, 804, 10.1016/j.jval.2012.06.016

Siebert, 2012, State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3, Value Health, 15, 812, 10.1016/j.jval.2012.06.014

Karnon, 2012, Modeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task force-4, Value Health, 15, 821, 10.1016/j.jval.2012.04.013

Pitman, 2012, Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force-5, Value Health, 15, 828, 10.1016/j.jval.2012.06.011

Eddy, 2012, Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force-7, Value Health, 15, 843, 10.1016/j.jval.2012.04.012

Claxton, 2008, Exploring uncertainty in cost-effectiveness analysis, Pharmacoeconomics, 26, 781, 10.2165/00019053-200826090-00008

Briggs, 1994, Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis, Health Econ, 3, 95, 10.1002/hec.4730030206

Gold, 2007

Brisson, 2006, Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs, Med Decis Making, 26, 434, 10.1177/0272989X06290485

2008

Lumley, 2002, Network meta-analysis for indirect treatment comparisons, Stat Med, 21, 2313, 10.1002/sim.1201

Everitt, 1998

Briggs, 2006

O'Hagan, 2006

Lunn, 2009, The BUGS project: evolution, critique and future directions, Stat Med, 28, 3049, 10.1002/sim.3680

Ades, 2002, Markov chain Monte Carlo estimation of a multi-parameter decision model: consistency of evidence and the accurate assessment of uncertainty, Med Decis Making, 22, 359, 10.1177/027298902400448920

Karnon, 2009, A hybrid cohort individual sampling natural history model of age-related macular degeneration: assessing the cost-effectiveness of screening using probabilistic calibration, Med Decis Making, 29, 304, 10.1177/0272989X08327491

Karnon, 2011, Calibrating models in economic evaluation: a comparison of alternative measures of goodness-of-fit, parameter search strategies, and convergence criteria, Pharmacoeconomics, 29, 51, 10.2165/11584610-000000000-00000

Kim, 2007, Multiparameter calibration of a natural history model of cervical cancer, Am J Epidemiol, 166, 137, 10.1093/aje/kwm086

Taylor, 2012, Incorporating calibrated model parameters into sensitivity analyses: deterministic and probabilistic approaches, Pharmacoeconomics, 30, 119, 10.2165/11593360-000000000-00000

Vanni, 2011, Calibrating models in economic evaluation: a seven step approach, Pharmacoeconomics, 29, 35, 10.2165/11584600-000000000-00000

Bojke, 2009, Characterizing structural uncertainty in decision analytic models: a review and application of methods, Value Health, 12, 739, 10.1111/j.1524-4733.2008.00502.x

Chapman, 2009, Accounting for uncertainty in health economic decision models by using model averaging, J R Stat Soc Ser A Stat Soc, 172, 383, 10.1111/j.1467-985X.2008.00573.x

Jackson, 2011, A framework for addressing structural uncertainty in decision models, Med Decis Making, 31, 662, 10.1177/0272989X11406986

Briggs, 1998, Confidence intervals or surfaces?, Health Econ, 7, 723, 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.0.CO;2-O

Stinnett, 1997, The negative side of cost-effectiveness analysis [letter], JAMA, 277, 1931, 10.1001/jama.1997.03540480031025

Claxton, 2002, A rational framework for decision making by the National Institute for Clinical Excellence (NICE), Lancet, 360, 711, 10.1016/S0140-6736(02)09832-X

Brennan, 2007, Calculating partial expected value of perfect information via Monte Carlo sampling algorithms, Med Decis Making, 27, 448, 10.1177/0272989X07302555

Groot Koerkamp, 2006, Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methods, Health Econ, 4, 383, 10.1002/hec.1064

Ades, 2004, Expected value of sample information calculations in medical decision modeling, Med Decis Making, 24, 207, 10.1177/0272989X04263162